Stockscreener 앱 받기
243.35
1.92%
-4.77
전일 마감가:
$248.12
열려 있는:
$247.44
하루 거래량:
823.52K
Relative Volume:
0.88
시가총액:
$17.54B
수익:
$3.07B
순이익/손실:
$493.70M
주가수익비율:
35.82
EPS:
6.7935
순현금흐름:
$468.90M
1주 성능:
+2.67%
1개월 성능:
-4.32%
6개월 성능:
-6.95%
1년 성능:
+7.65%
1일 변동 폭
$243.19
$249.47
1주일 범위
$237.41
$252.41
52주 변동 폭
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
243.35 | 17.54B | 3.07B | 493.70M | 468.90M | 6.7935 |
ISRG
Intuitive Surgical Inc
|
452.66 | 160.77B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
73.34 | 35.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
41.36 | 33.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
220.47 | 32.12B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical CEO plans exit after 11 years, succession process underway - MSN
Upcoming drug delivery talk sees West Pharmaceutical Services stock fall 1.92% amid weak technical signals - Traders Union
West Pharmaceutical Services (MIC:WST-RM) NonCurrent Deferr - GuruFocus
Nordea Investment Management AB Increases Position in West Pharmaceutical Services, Inc. $WST - marketbeat.com
WST (West Pharmaceutical Services) Predictability Rank - GuruFocus
Q2 2024 West Pharmaceutical Services Inc Earnings Call Transcript - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vanguard (NYSE: WST) reports 0% stake after January 12, 2026 realignment - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
Riverbridge Partners LLC Has $87.66 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
SG Americas Securities LLC Boosts Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now? - Insider Monkey
West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway - Insider Monkey
West Pharmaceutical Services to present FluroTec Barrier Film benefits at ChemPharma Summit - Traders Union
Buyback Watch: Is West Pharmaceutical Services Inc stock showing strong momentumMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
West Pharma declares dividend as Exton giant signals steady footing - MSN
Assenagon Asset Management S.A. Has $69.06 Million Stake in West Pharmaceutical Services, Inc. $WST - marketbeat.com
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical declares $0.22 dividend - msn.com
Pharmaceutical Packaging and cGMP: Trusted Companies Setting New Standards - Medical Device Network
West Pharmaceutical Services, Inc. $WST is Seilern Investment Management Ltd's 7th Largest Position - marketbeat.com
West CEO Eric Green plans retirement pending successor search - MSN
Exton-based West Pharmaceutical reports higher Q4 sales, earnings - MSN
WST launches Synchrony S1 prefillable syringe at Pharmapack - msn.com
Here is why West Pharmaceutical Services, Inc. (WST) is strongly favored by hedge funds - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Here's Why You Should Add McKesson Stock to Your Portfolio Now - TradingView
West Pharmaceutical Services, Inc. $WST Shares Purchased by JPMorgan Chase & Co. - MarketBeat
3 Overvalued Stocks: High P/E Ratios Signal Risk Amid Slowing GrowthNews and Statistics - IndexBox
West Pharmaceutical Services expert to present medical device biocompatibility strategy at key summit - Traders Union
Pharmaceutical Packaging Market: Serialization & Track-and-Trace Compliance, Global Regulatory Mandates, & Industry Growth Outlook - vocal.media
West Pharmaceutical Stock (ISIN: US9523901012) Faces Pressure Amid Pharma Supply Chain Shifts and Ea - AD HOC NEWS
West Pharmaceutical Services at KeyBanc Forum: Strategic Growth Insights By Investing.com - Investing.com Canada
West CEO Eric Green Plans Retirement Pending Successor Search - MyChesCo
West Pharmaceutical declares dividend, authorizes $1B buyback - MSN
West Pharmaceutical Services showcases device innovation at COPHEX Korea event - Traders Union
Moore Capital Management LP Purchases New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Holocene Advisors LP Takes $49.09 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Improved Investor Confidence Boosted West Pharmaceutical Services (WST) - MSN
West Pharmaceutical Services urges industry to adapt as USP draft chapters reshape contamination control - Traders Union
The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services - The Globe and Mail
Iron Triangle Partners LP Purchases New Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Hillman Capital Management Inc. Takes $2.70 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)? - Yahoo Finance
Cinctive Capital Management LP Makes New $3.76 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Nigeria
How Leadership Transition And Governance Debate At West Pharmaceutical (WST) Has Changed Its Investment Story - simplywall.st
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
자본화:
|
볼륨(24시간):